NCT01405469

Brief Summary

This study intends to investigate the feasibility, safety and efficacy of peroral endoscopic myotomy for the treatment of achalasia in a single center setting in Europe.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2010

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 26, 2011

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 29, 2011

Completed
3.3 years until next milestone

Results Posted

Study results publicly available

December 2, 2014

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

October 15, 2019

Status Verified

October 1, 2019

Enrollment Period

7 months

First QC Date

May 26, 2011

Results QC Date

September 4, 2014

Last Update Submit

October 6, 2019

Conditions

Keywords

AchalasiaHeller myotomyDysphagiaPeroral Endoscopic Myotomy

Outcome Measures

Primary Outcomes (1)

  • Treatment Success Defined as Symptom Relief 3 Months After Treatment Based on an Eckhardt Score ≤ 3

    eckhardt score is a score to evaluate achalasia discomfort in patients. Patients are being interrogated for dysphagia, regurgitation, and retrosternal pain , correlated with the time frame of occurrence. "with every meal" giving 3 points," daily" (2 points), "sometimes" (1 Point) or "no" (0 Points), as well as weight loss,(\>10 kg= 3 points, 5-10 kg=2 points, 0-5 kg=1 point, None=0 points. Scale range is from 0 Points (no achalasia) up to 12 points for the worst achalasia symptoms.

    3 months after treatment

Secondary Outcomes (8)

  • mmHg of the Lower Esophageal Sphincter 3 Months After POEM Procedure

    manometry at 3 month after therapy

  • Number of Participants With Reflux Symptoms

    during procedure, and 3 and 6 months, and 1, 2 and 5 years after treatment

  • Number of Participants With Procedure-related Adverse Events

    procedure to 3 months post procedure

  • Medication 3 Months After POEM

    3 months

  • Duration Time Procedure

    procedure

  • +3 more secondary outcomes

Study Arms (1)

Peroral Endoscopic Myotomy

EXPERIMENTAL

Patients with achalasia who are designed to either get balloon dilatation or have botulinum toxin injection, or to have surgical intervention (Heller myotomy)for treatment

Other: Peroral Endoscopic Myotomy

Interventions

A forward-viewing upper endoscope is used with a transparent distal cap attachment. Carbon dioxide gas is necessary for insufflation during the procedures. An endoscopic knife is used to access the submucosa, dissect the submucosal tunnel and also to divide circular muscle bundles over a length of approximately 10cm, extending 2-3cm onto the cardia. An electric generator is used with spray coagulation mode. A coagulating forceps is used for hemostasis as needed. Closure of the mucosal entry site is performed using standard endoscopic clips

Peroral Endoscopic Myotomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient with symptomatic achalasia and pre-op barium swallow, manometry and esophagal-gastro-duodenoscopy which are consistent with the diagnosis
  • persons of age \> 18 years with medical indication for surgical myotomy or Endoscopic balloon dilatation
  • Signed written informed consent.

You may not qualify if:

  • Patients with previous surgery of the stomach or esophagus
  • Patients with known coagulopathy
  • Previous achalasia-treatment with surgery
  • Patients with liver cirrhosis and/or esophageal varices
  • Active esophagitis
  • Eosinophilic esophagitis
  • Barrett's esophagus
  • Pregnancy
  • Stricture of the esophagus
  • Malignant or premalignant esophageal lesion
  • Candida esophagitis
  • Hiatal hernia \> 2cm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitätsklinikum Hamburg-Eppendorf, Klinik für Interdisziplinäre Endoskopie

Hamburg, 20246, Germany

Location

Related Publications (2)

  • Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, Satodate H, Odaka N, Itoh H, Kudo S. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010 Apr;42(4):265-71. doi: 10.1055/s-0029-1244080. Epub 2010 Mar 30.

    PMID: 20354937BACKGROUND
  • von Renteln D, Inoue H, Minami H, Werner YB, Pace A, Kersten JF, Much CC, Schachschal G, Mann O, Keller J, Fuchs KH, Rosch T. Peroral endoscopic myotomy for the treatment of achalasia: a prospective single center study. Am J Gastroenterol. 2012 Mar;107(3):411-7. doi: 10.1038/ajg.2011.388. Epub 2011 Nov 8.

Related Links

MeSH Terms

Conditions

Esophageal AchalasiaDeglutition Disorders

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Results Point of Contact

Title
Prof. Dr. Thomas Rösch, Principal Investigator
Organization
University Hospital Hamburg-Eppendorf

Study Officials

  • Thomas Roesch, Prof. Dr.

    Universitätsklinikum Hamburg-Eppendorf

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2011

First Posted

July 29, 2011

Study Start

November 1, 2010

Primary Completion

June 1, 2011

Study Completion

November 1, 2016

Last Updated

October 15, 2019

Results First Posted

December 2, 2014

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations